Opus Capital Group, LLC Sanofi Transaction History

Opus Capital Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 29, 2021	SELL	$49.36 - $54.25 $226,809 - $249,278	-4,595 Closed	0 $0
Q3 2020 Oct 30, 2020	SELL	$49.47 - $53.77 $26,219 - $28,498	-530 Reduced 10.34%	4,595 $231,000
Q2 2020 Jul 31, 2020	BUY	$42.91 - $52.5 $10,083 - $12,337	235 Added 4.81%	5,125 $262,000
Q1 2020 Apr 30, 2020	BUY	$38.02 - $51.66 $24,332 - $33,062	640 Added 15.06%	4,890 $214,000
Q4 2019 Jan 31, 2020	BUY	$44.25 - $50.86 $188,062 - $216,155	4,250 New	4,250 $213,000
Q1 2018 May 04, 2018	SELL	$38.98 - $45.76 $280,461 - $329,243	-7,195 Closed	0 $0
Q3 2017 Nov 07, 2017	BUY	$47.04 - $50.34 $338,452 - $362,196	7,195	7,195 $358,000

807

253M

2.6M

1.64M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $133B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Opus Capital Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Opus Capital Group, LLC with notifications on news.